Research Article
Growth Hormone and Disease Severity in Early Stage of Multiple Sclerosis
Table 2
GH and IGF-I levels in MS patients, OND and HC subjects, according to sex and age.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mann-Whitney -test was used to compare MS versus OND and MS versus HC; Kruskal-Wallis test was employed. GH in MS female shows a trend for lower value than in OND and HC females. Values are expressed as means ± SD. MS: Multiple Sclerosis; OND: other neurological disease; HC: healthy controls; M: male; F: female. |